Wugen

Developer of CAR-T cell therapy for treatingT-cell malignancies

placeSt. Louis, Missouri, United States calendar_todayFounded 2018 groups81 employees language wugen.com

Social engagement

Social engagement: 5.8K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include BioGenerator, Abingworth, Tybourne Capital Management, Fidelity Investments.

Investor typeCountShare
Venture capital538%
Private equity323%
Bank & private debt18%
Other / undisclosed431%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

4 Jun 2026 · Senior Process Validation Engineer / Scientist

9 Oct 2025 · VP Finance · St. Louis, MO

8 Sep 2025 · Data Science and Biometrics, Data Management, Drug Safety, Clinical Science, Clinical Operations

Based on job postings tracked across public sources.

Recent activity

2 Apr 2026
Partnership
Wugen
21 Jan 2026
Milestone
regulatory
5 Dec 2025
Event
2025 ASH Annual Meeting
Coming soon